Back to search
Childhood Solid Neoplasm
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Childhood Solid Neoplasm trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Childhood Solid Neoplasm trials you may qualify forBackground: All childhood cancers are rare, but some are called very rare. Very rare cancers are diagnosed in 2 or fewer out of 1 million people each year. Res…
The phase I portion of this study is designed for children or adolescents and young adults (AYA) with a diagnosis of a solid tumor that has recurred (come back…
This phase I/II trial tests the safety, side effects and best dose of DT2216 in combination with irinotecan and how well it works in treating children, adolesce…
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patient…
The purpose of the study is to determine the appropriate pediatric dosage and evaluate the pharmacokinetics (PK) and safety of Lutetium Lu 177 Edotreotide Targe…
Background: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small pe…
This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with soli…
This is a phase I, open-label, non-randomized study that will enroll pediatric and young adult research participants with relapsed or refractory non-CNS solid t…